Discontinuation of Depo-Provera® and Depo-Ralovera® Vials

HPS Pharmacies wishes to advise that Pfizer are discontinuing both medroxyprogesterone vials.
The products will be delisted from the PBS and discontinued on the following dates:

Depo-Provera®
Medroxyprogesterone 150 mg/mL vial
ARTG 12300
Discontinuation Date: 1st July 2024

Depo-Ralovera®
Medroxyprogesterone 150 mg/mL vial
ARTG 44464
Discontinuation Date: 1st November 2024

Pfizer has launched Depo-Provera® 150 mg/mL pre-filled syringe (ARTG 401610) on 1st June 2024 with PBS listing and is now available at wholesalers.

Retain this notice in a prominent position, including in other related business units for at least one month. Report any problems identified with medicines, vaccines or medical devices to the TGA.

Should you require further information rearding this matter, please contact Pfizer on 1800 629 921
or your pharmacist at HPS Pharmacies.